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Introduction
Cytochrome c oxidase (complex IV or CcO), is the main final acceptor of the electron transfer chain in mitochondria, catalyzing oxygen reduction coupled to proton pumping [2] . It is composed of 10-13 subunits and its biogenesis involves both mitochondrion-and nucleus-encoded polypeptides [3] [4] [5] [6] . In yeast, as in the vast majority of eukaryotes, the three larger subunits of CcO are encoded in the mitochondrial genes COX1, COX2 and COX3 and the corresponding CcO subunits are synthesized in the organelle [7] , while the eight additional subunits are nucleus-encoded and therefore synthesized in the cytosol [8] . Normally, Cox2 is synthesized as a precursor in the mitochondrial matrix with a 15 amino acid leader sequence [9] [10] [11] and cotranslationally inserted in the inner mitochondrial membrane [12] in a process mediated by the Oxa1 translocase [13] [14] [15] . As a final step of Cox2 biogenesis, the leader sequence of 15 residues is removed by a protease located in the mitochondrial inter-membrane space (IMS) [9, 11] giving rise to the mature subunit with both N-and C-termini exposed to the IMS.
Allotopic expression refers to the expression from the nucleus of a gene that normally resides in the mitochondrion [16] ; it is considered the basis for the eventual development of gene therapies to treat human mitochondrial diseases [17, 18] . Allotopic expression requires targeting of the cytosol-synthesized protein to the mitochondrion, internalization into the organelle, proteolytic maturation, and functional assembly into the corresponding OXPHOS complex. Yeast is an outstanding model for allotopic expression since the tools for genetic manipulation in this organism are very accessible [19] . The original contribution of Banroques et al. [20] used the cytosol-synthesized soluble yeast bI4 maturase to complement the activity of its defective, mitochondrion intron-encoded counterpart. Other studies pioneered the allotopic expression of membrane-bound mitochondrial proteins exhibiting one transmembrane stretch (TMS). A yeast strain with deleterious mutations in the mitochondrial ATP8 gene (encoding subunit Atp8 or A6L of mitochondrial ATP synthase) was complemented with an ATP8 gene recoded to allow its expression from the nucleus [21, 22] . The mitochondrial targeting sequence (MTS) of subunit Atp9 from Neurospora crassa allowed the yeast Atp8 protein to be targeted to mitochondria, internalized into the organelle, and functionally integrated into complex V (F 1 Fo-ATP synthase). The allotopicallyexpressed Atp8 subunit restored ATP synthesis to levels similar to those observed in the wild-type (WT) strain and its association to the mature ATP synthase complex was unequivocally demonstrated [23, 24] .
Recently, Cox2 was allotopically-expressed in a yeast mutant containing a non-functional COX2 mitochondrial gene (Δcox2 mutant) [1] . Two requirements were fulfilled in order to complement a Δcox2 strain with a cytosol-synthesized Cox2: the addition of the MTS of either the inner mitochondrial membrane proteins Atp9 or Oxa1, and the substitution of tryptophan 56 by arginine (W56R mutation) in the Cox2 sequence (Cox2 W56R ). This single point mutation, identified after a round of random mutagenesis, was enough to diminish the mean hydrophobicity of the first TMS of COX2 W56R to such a degree that allowed the cytosol-synthesized protein to be imported into mitochondria. Transformation of the respiratory-deficient mutant with a vector expressing Cox2 W56R allowed the growth of the resulting Δcox2+Cox2 W56R complemented strain in non-fermentable carbon sources, although only 30-40% of the respiratory capacity of the WT strain was recovered [1] . This report prompted us to explore whether the partial recovery of respiratory rate was due to a diminished activity of CcO carrying the allotopically-expressed Cox2 W56R subunit or whether it could be attributed to lower steady-state accumulation levels of complex IV. Here, we provide a biochemical characterization of CcO containing the allotopically-expressed Cox2 W56R subunit and show that this mutant subunit was correctly processed in mitochondria and was able to restore the mitochondrial synthesis of Cox1 to levels comparable to the ones found in the WT strain.
Materials and methods

Gene constructs
The gene encoding COX2 of Saccharomyces cerevisiae, containing the point mutation W56R, was recoded for expression from the nucleus and a region encoding the MTS of OXA1 was added in the 5′ end, as previously described [1] . The construct was chemically synthesized (GeneScript, Piscataway, NJ, USA) and cloned in the pFL61 vector that contains a phosphoglycerate kinase promoter, a kind gift from Dr. Patrice Hamel (Ohio University, Columbus, USA). Yeast cells were transformed in the presence of lithium acetate and salmon sperm DNA as described [25] .
2.2. Strains, culture conditions, and isolation of yeast mitochondria S. cerevisiae strains used in this study were NB40-36A (MATα, lys2, arg8::hisG, ura3-52, leu2-3, 112, [rho +]) and NAB97 (MATa, lys2, arg8::hisG, ura3-52, leu2-3, 112, his3-deltaHindIII, ydr494wHA, cox2-22, [rho +]). The strains were a kind gift from Prof. Thomas Fox, Cornell University (USA). Cells were grown in fermentable medium YPD (1% yeast extract, 2% bactopeptone, and 2% glucose). Nonfermentable media were lactate medium (3 g yeast extract, 1 g KH 2 PO 4 , 1 g NH 4 Cl, 0.5 g CaCl 2 ·H 2 O, 0.5 g NaCl, and 1.1 g MgSO 4 ·7H 2 O, 0.3 ml of a 1% FeCl 3 solution and 22 ml 90% lactate) [26] and YPEG (1% yeast extract, 2% bacto-peptone, 3% ethanol and 3% glycerol). Minimal medium (0.17% yeast nitrogen base without amino acids) was supplemented with 2% glucose, raffinose or galactose and specific amino acids. All cells were grown at 160 rpm in a New Brunswick shaker in a constant temperature room at 30°C for 15 h and were harvested at the logarithmic growth phase. Cells were washed with water and resuspended in extraction buffer (0.6 M mannitol, 10 mM maleic acid and 0.1% BSA, pH 6.8 adjusted with triethanolamine) and disrupted using a Bead Beater cell homogenizer (Biospec Products) with 0.45 mm glass beads (3× 20 second pulses separated by 40 second resting periods). To isolate mitochondria, the homogenate was differentially centrifuged as described [27] and protein concentration was determined by biuret [28] . Mitochondria were frozen and stored at −70°C for further use.
Isolation of CcO and enzymatic activities in chromatography eluates
CcO was isolated following a protocol previously described for the algal enzyme [29] . Briefly, yeast mitochondria were solubilized with 2 g of n-dodecyl-beta-D-maltoside (LM) per g of protein at a protein concentration of 10 mg/ml in 1 mM MgSO 4 , 1 mM phenylmethyl-sulfonyl fluoride (PMSF), 50 mM Tris, pH 8.0, plus 50 μg of N-alpha-tosyl-L-lysyl-chloromethyl-ketone (TLCK) mL −1
. The extract was centrifuged at 100,000 ×g for 30 min and layered on top of a DEAE-Biogel A column. The column was washed with 3 volumes of 50 mM Tris, 1 mM MgSO 4 and proteins were eluted with a 0-200 mM NaCl gradient (two column volumes) and washed with 200 mM NaCl (1 column volume). In this wash a fraction enriched in CcO was recovered. In addition, a crude fraction of bc 1 complex was also recovered after eluting the column with 400 mM NaCl in the same buffer. Fractions (2.5 ml) were collected and the protein content of each fraction was estimated spectrophotometrically at 280 nm. Twenty microliters of each fraction were collected in a well of a 96-well plate and CcO activity in the fractions was assayed in the presence of 50 mM phosphate buffer (sodium) pH 7.4, 2.5 mg·mL −1 horse-heart cytochrome c, and 1 mg·mL −1 diaminobenzidine [30] . Absorbance at 490 nm was quantitated in a multimodal micro plate reader Synergy Mix (Biotek). The fractions enriched in CcO were recovered and concentrated by ultrafiltration in a YM100 membrane (Amicon). After adding glycerol to a final concentration of 10%, the sample was loaded onto 15 to 40% glycerol gradients in 20 mM Tris-HCl (pH 8.0), 1 mM sodium EDTA, and 0.1 mg/ml of LM. The gradients were centrifuged at 40,000 ×g for 17 h in a swing out rotor. Protein concentrations were determined as previously described [31] .
Cytochrome measurements using differential spectrophotometry
Mitochondria were solubilized with LM (2 mg of detergent per mg of protein) and centrifuged at 100,000 ×g for 30 min. Absorbance spectra were recorded from 500 to 680 nm in a DW2000 Aminco spectrophotometer in the presence of ferricyanide to obtain the oxidized spectra, which was assigned as baseline. Then, the reduced spectrum was recorded after addition of sodium dithionite to the sample cuvette. Differential absorption coefficients (reduced minus oxidized) were: for both horse heart and yeast soluble cytochrome c (550-540 nm) 19 [33] , and for cytochrome c 1 (553-541 nm) 17.5 mM
Oxygen uptake measurements
The rate of oxygen consumption was measured in an oxygen meter model 782 (Warner/Strathkelvin Instruments) with a Clark type electrode in a 0.1 mL water-jacketed chamber at 30°C [35] and data were analyzed using the 782 Oxygen System software (Warner/Strathkelvin Instruments). The assay contained 50 mM Hepes pH 7.4, 0.1% LM, 10 mM ascorbate, 200 μM tetramethylpara-phenylenediamine (TMPD), 50 nM CcO and 50 μM horse heart cytochrome c or yeast cytochrome c as indicated. When needed, 100 μM KCN was added to inhibit CcO activity.
Gel electrophoresis and in-gel enzymatic activities
Denaturing gel electrophoresis was carried in a SDS-tricine-PAGE system [36] , or when indicated, in a SDS-glycine-PAGE system [37] .
Sample preparation and Blue Native polyacrylamide gel electrophoresis (BN-PAGE) were carried out as described [38] . Briefly, mitochondria were washed in 250 mM sorbitol, 50 mM Bis-Tris (pH 7.0), and centrifuged at 12,000 ×g for 10 min at 4°C. The pellet was resuspended in sample buffer [750 mM aminocaproic acid, 50 mM Bis-Tris (pH 7.0)] and solubilized with 2.0 g LM per g of protein (1% LM) for 30 min and centrifuged at 100,000 ×g at 4°C for 30 min. When indicated, mitochondria were solubilized in the same sample buffer but in the presence of 4.0 g digitonin per g of protein (2% digitonin). The supernatants (1 mg protein) were loaded on 5-15% polyacrylamide gradient gels. The stacking gel contained 4% (w/v) polyacrylamide. In-gel CcO activity was determined using 3, 3′-diaminobenzidine and cytochrome c as described [39, 40] . In-gel ATPase activity was visualized after BN-PAGE [41, 42] . The gels were incubated for 3 h in a buffer containing 270 mM glycine and 35 mM Tris-HCl (pH 8.4). Then, the following additions were made: 8 mM ATP, 14 mM MgSO 4 , and 0.2% Pb(NO 3 ) 2 . Once the white precipitates of lead phosphate became visible, the reaction was stopped with 50% methanol.
Immunoassays
From BN-or SDS-tricine-PAGE, proteins were electro-transferred onto a nitrocellulose Trans-Blot membrane (BioRad) for immunedetection [43] . Membranes were washed, blocked, and incubated with the following monoclonal antibodies (Invitrogen; Molecular Probes) anti-human Cox1 (1:3000 for 8-12 h), anti-yeast Cox2 (1:3000 for 8 h), or anti-yeast Cox3 (1:3000 for 8-12 h) using an alkaline phosphatase-conjugated anti-mouse IgG (1:3000 for 2 h) as secondary antibody. When Western blots were carried out with anti-citrate synthase (1:1000 for 1 h) or anti-bovine Rieske ironsulfur protein (1:5000 for 8 h), the secondary antibody used was an alkaline phosphatase-conjugated anti-rabbit IgG (1:3000 for 2 h). Before carrying a second Western blot reaction with a different primary antibody, the membrane was incubated for 30 min at 60°C in the presence of 2% SDS, 62.5 mM Tris-HCl pH 6.8 and 100 mM β-mercapto-ethanol. The anti-citrate synthase antibody was a kind gift from Prof. Thomas Fox, Cornell University (USA).
Analysis of mitochondrial protein synthesis
In vivo pulse-chase labeling of cells with [ 35 S] methionine in the presence of cycloheximide was performed as described [44] , except that cells were grown initially in minimal medium with 2% raffinose, and previous to labeling, cells were transferred to a medium lacking methionine for 30 min. Then, cells were labeled with 15 μCi of [ 35 S] methionine for 15 min, were washed with a buffer containing 0.6 M sorbitol and 20 mM Hepes pH 7.4, and then chased with cold 10 mM methionine for 1 to 4 h at 30°C. After labeling, cells were incubated in ice and disrupted with glass beads in order to isolate mitochondria [45] . The radiolabeled mitochondrion-synthesized polypeptides were subjected to SDS-glycine-PAGE on a 16% polyacrylamide gel [37] . The gel was dried and analyzed in a Typhoon 8600 Phosphorimager (GE Healthcare).
N-terminal sequencing
The isolation of polypeptides for N-terminal sequencing was carried out as previously described [46] . The polypeptides of CcO were resolved by SDS-tricine-PAGE, transferred to a PVDF membrane, stained with Coomassie Brilliant Blue and the bands that corresponded to Cox2 were carefully excised from the membrane. N-terminal sequencing by automated Edman degradation of Cox2 was carried out by Dr. J. d'Alayer on an Applied Biosystems Sequencer at the Laboratoire de Microséquençage des Protéines, Institut Pasteur, Paris (France).
Tandem mass spectrometry (LC/ESI-MS/MS)
Sample preparation
After SDS-tricine-PAGE, the protein bands were excised from the Coomassie stained gel and destained with 50% (v/v) methanol 5% (v/v) acetic acid for 12 h. The destained gels were washed with deionized water, soaked for 10 min in 100 mM ammonium bicarbonate, cut into small pieces, dehydrated with 100% acetonitrile and vacuumdried. Proteins were reduced with 10 mM DTT and S-alkylated cysteine with 100 mM iodoacetamide in 100 mM ammonium bicarbonate. In gel digestion was performed by adding 30 μL of modified porcine trypsin solution (20 ng/μL) in 50 mM ammonium bicarbonate followed by overnight incubation at room temperature. Peptides were extracted with 50% (v/v) acetonitrile 5% (v/v) formic acid twice for 30 min each time with sonication. The extracts were dried down under vacuum and resuspended in 20 μL of 0.1% formic acid.
LC/MS/MS
HPLC/MS/MS analysis of peptides was carried out using an integrated nano-LC_ESI_MS/MS system. A NanoAcquity ultraperformance liquid chromatograph (UPLC) (Waters Corporation) coupled to a Q-ToF Synapt G2 high definition mass spectrometer (Waters Corporation) equipped with a NanoLockSpray ion source. The mass spectrometer was calibrated with a NaCI solution (mass range: 50 to 2000 Da) and operated in ESI positive V-mode at a resolution of 10,000 full width at half height (fwhh). Spectra were acquired in automated mode using data-dependent acquisition (DDA). [Glu 1] fibrinopeptide B solution (100 fmol/μL) was infused through the reference sprayer of the NanoLockSpray source at a flow rate of 0.5 μL/min and was sampled at 30 s intervals during the acquisition. MS survey scans of 1 s over the m/z range 300 to 1600 were used for peptide detection followed by two MS/MS scans of 2 s each (m/z 50 to 2000) of detected precursors. Collision energies were automatically adjusted based upon the ion charge state and the mass. The five most intensive precursor ions of charge 2+, 3+ or 4+ were interrogated per MS/MS switching event. Dynamic exclusion for 60 s was used to minimize multiple MS/MS events for the same precursor. The data were postacquisition lock mass corrected using the doubly protonated monoisotopic ion of [Glu 1] fibrinopeptide.
Data processing and protein identification
DDA raw data files were processed and searched using the ProteinLynx Global Server version 2.4 (PLGS) software (Waters Corporation).The default parameter settings included: Perform lockspray calibration with a lockmass tolerance of 0.1 Da. Background subtract type, adaptative. Deisotoping type, medium. The processed DDA was queried against the S. cerevisiae database (http://www. Uniprot.org/) appended with the Cox2 W56R sequence. Trypsin was set as the digest reagent and one missed cleavage site was allowed. Mass tolerances of 30 ppm and 0.05 Da were used for precursor and product ions, respectively. Carbamidomethyl-cysteine was the fixed modification. Met oxidation and Gln-Asn deamidation were set as variable modifications.
In silico protein analysis
The sequences of yeast CcO subunits were modeled with SwissModel (http://swissmodel.expasy.org/) [47] [48] [49] using as template bovine heart cytochrome c oxidase at the fully oxidized state (PDB ID: 2OCC) [50] . Models were made in Automated Mode, except for the one of Cox7a, which was done in Alignment Mode. The following yeast sequences were modeled upon their corresponding templates: Cox1 encoded by COX1 (NCBI accession number NP_009305) on PDB ID: 2occA; Cox2 encoded by COX2 (NP_009326) on PDB ID: 2occB; Cox3 encoded by COX3 (NP_009328) on PDB ID: 2occC; Cox4 encoded by COX4 (NP_011328) on PDB ID: 2occF; Cox5 encoded by COX5 Yeast mutants carrying a defective mitochondrial COX2 gene (Δcox2) are unable to grow in non-fermentable carbon sources [52] . The Δcox2 yeast mutant used in this work grew in fermentable carbon sources including glucose, galactose and raffinose (Fig. 1A , upper panels), but as expected, failed to grow in the presence of nonfermentable carbon sources like lactate or a mixture or ethanol-glycerol (Fig. 1A, lower panels) . In contrast, the WT strain grew in both fermentable and non-fermentable carbon sources, (Fig. 1A, all panels) . The yeast mitochondrial COX2 gene was recoded and cloned into an expression vector, giving rise to the Cox2 W56R precursor containing the MTS of Oxa1, the natural 15 amino acid leader sequence of Cox2 and the W56R mutation described earlier [1] . The Δcox2 mutant was transformed with this construct, and the resulting transformants were challenged to grow on non-fermentable carbon sources. In solid media, the complemented strain (Δcox2+Cox2 W56R transformant) grew faster in lactate than in ethanol and glycerol, albeit in both cases, at lower rates as compared to the WT strain (Fig. 1A, lower To identify the presence of Cox2 in the different strains, yeast was grown in a galactose medium and whole cell protein extracts were loaded onto gels to perform SDS-tricine-PAGE. Then, Western blot analysis was carried out using specific anti-yeast Cox2 antibodies. Fig. 2A shows the presence of mature Cox2 in whole cell protein extracts from the WT strain (mCox2 WT ; Fig. 2A lane 1) , from the Δcox2+Cox2 W56R transformant (mCox2
W56R
; Fig. 2A lane 4) , from isolated mitochondria from the WT strain ( Fig. 2A, lane 5) , and from a crude fraction of isolated bc 1 complex (Fig. 2A, lane 6) . In contrast, in the Δcox2 mutant (Fig. 2A, lane 2) and the Δcox2 mutant transformed with an empty vector ( Fig. 2A, lane 3 ; Fig. 2B lane 4) . No Cox2 band was observed in the Δcox2 mutant (Fig. 2B, lane 2) or in the Δcox2 mutant transformed with an empty vector (Fig. 2B, lane 3) . The Cox2 W56R precursor protein (
), was present only in mitochondria of the Δcox2+Cox2 W56R transformant (Fig. 2B, lane 4) , suggesting that a fraction of this precursor may have been internalized into the organelle. To ensure that equivalent amounts of mitochondrial protein were loaded in the blot, the nylon membrane was re-blotted with antibodies raised against citrate synthase (CS). As judged by the immunochemical reaction, equivalent amounts of CS seem to be present in all the analyzed mitochondrial fractions (Fig. 2B,   lanes 1-4) . The ratio of mCox2 WT to CS, as judged by densitometry was 3.65 ( Fig. 2B, lane 1) , while the ratio of mCOX2 W56R to CS was 1.60
( Fig. 2B, lane 4) , indicating that the mature form of the cytosolsynthesized Cox2 W56R was only a fraction of the mitochondrionsynthesized Cox2
WT
. A parallel blot, decorated with antibodies against the Cox2 subunits and against the bovine Rieske iron sulfur protein of the bc 1 complex revealed similar results (Fig. 2C, lanes 1-4) . ATPase activity staining; lanes 10-12 in-gel CcO activity. Arrows denote the in-gel activity stained bands of the F 1 Fo-ATPase (V), and CcO. B) Visible spectra of mitochondria obtained from the WT strain, the Δcox2 mutant and the Δcox2+Cox2 W56R transformant. 400 μg of mitochondrial protein solubilized with LM from each strain were used to obtain the dithionite-reduced minus ferricyanide-oxidized spectra. The identities of the corresponding heme groups are indicated. C) Western blot analysis of LM-solubilized mitochondria from the WT strain and the Δcox2+Cox2 W56R transformant subjected to BN-PAGE followed by 2D-SDS-PAGE. Blots were decorated with an anti-Cox3 antibody. Aggregates not entering the gel are denoted as A, dimeric CcO as IV 2 , the two forms of monomeric CcO as IV, and the gel front as F. No sub-complex containing Cox3 exhibiting a higher mobility than complex IV could be observed. D) Mitochondria obtained from the WT strain and the Δcox2+Cox2 W56R transformant were solubilized with 2% digitonin, separated by BN-PAGE and stained for in-gel CcO activity in the absence (lanes 1 and 2) or presence of KCN (lanes and 4). Arrows denote the in-gel activity stained bands of monomeric CcO (IV), dimeric CcO (IV 2 ), and of CcO associated to supercomplexes (III 2 IV 1 and III 2 IV 2 ). E) Western blot analysis of digitonin-solubilized mitochondria from the WT strain and the Δcox2+Cox2 W56R transformant subjected to BN-PAGE followed by 2D-SDS-PAGE. Blots were decorated with an anti-Cox3 antibody (two upper panels), stripped and re-decorated with an anti-FeS antibody (two lower panels). Aggregates at the start of the gel are denoted as A, and the identity of the observed complexes and supercomplexes are indicated. The presence of free, dimeric bc 1 complex (III 2 ) is clearly visible in the bottom panel.
Resolution of complex IV by
study the OXPHOS complexes of yeast [54] . In order to compare CcO contents among the WT, the Δcox2 mutant and the Δcox2 + Cox2 W56R transformant, the strains were grown in a raffinose-containing medium. Mitochondria were isolated, solubilized with LM and subjected to BN-PAGE. Fig. 3A shows the polypeptide pattern of the mitochondrial complexes as obtained after BN-PAGE (Fig. 3A, lanes 1-3) , and after fixing and staining with Coomassie Brilliant Blue (Fig. 3A , lanes 4-6). In-gel activity staining was carried out in order to identify some of the main mitochondrial complexes. To localize the active yeast F 1 Fo-ATPase (complex V) on BN-PAGE, duplicate lanes were incubated in the presence of ATP and Pb(NO 3 ) 2 . A band of 540 kDa was able to hydrolyze ATP, as indicated by the formation of a lead phosphate precipitate (Fig. 3A, lanes 7-9) . All mitochondria, including the Δcox2 mutant, exhibited equivalent amounts of complex V as judged by Coomassie Blue staining (Fig. 3A, lanes 4-6) , and in-gel activities (Fig. 3A, lanes 7-9) . When in-gel staining was carried out for CcO activity, two close bands revealed activity in the WT and in the Δcox2 + Cox2 W56R strains (Fig. 3A, lanes 10 and 12) , while no in-gel activity could be detected in the Δcox2 mutant, as expected (Fig. 3A , lane 11). Two close bands exhibiting CcO activity after BN-PAGE have been previously described in yeast mitochondria. The upper band probably corresponds to the monomeric holoenzyme CcO complex, while the lower one represents a CcO lacking subunit Cox6 (equivalent to bovine subunit Cox6a) that may partially dissociate during BN-PAGE [52] . The Δcox2 + Cox2 W56R transformant exhibited in-gel CcO activity, albeit with 40% lower intensity than the one observed for the WT, as judged by densitometry. The lower activity of CcO could be attributed either to a lower enzymatic activity or to lower steady-state accumulation levels of complex IV. In order to estimate the ratio of CcO to cytochrome bc 1 complex in the WT strain and in the Δcox2+Cox2 W56R transformant, the content of aa 3 -type hemes and b-type hemes were determined from reduced minus oxidized difference spectra (Fig. 3B) . For this purpose, mitochondria from WT and the Δcox2+Cox2 W56R transformant grown in a lactate liquid medium and mitochondria from the Δcox2 mutant grown in galactose were solubilized with LM, centrifuged, and difference spectra of the supernatants were recorded (dithionite-reduced minus ferricyanide-oxidized). As expected, mitochondria from the Δcox2 mutant exhibited undetectable levels of type aa 3 hemes and it also exhibited diminished levels of bc 1 complex (160 pmoles of heme b per mg of protein). In contrast, the WT strain exhibited 266 pmoles of heme aa 3 per mg of protein, and the Δcox2+Cox2 , these data further supports the observation that there is approximately 40% less steady-state accumulation levels of CcO in the allotopically-transformed strain as compared to the WT strain. We asked whether partially-assembled CcO sub-complexes were present in the Δcox2+Cox2 W56R transformant. For this purpose, mitochondria were isolated, solubilized with LM, subjected to BN-PAGE followed by second-dimension denaturing SDS-tricine-PAGE, transferred to a PVDF membrane and assayed by Western blotting using an anti-Cox3 antibody. No CcO sub-complex, at least no one containing Cox3, could be detected (Fig. 3C) . Since only 60% of assembled CcO is present in the Δcox2+Cox2
W56R
transformant as compared to the WT strain, we thought of interest to explore the amount of supercomplexes present in both strains. For this purpose, mitochondria solubilized with 2% digitonin were subjected to BN-PAGE. Fig. 3D shows the polypeptide pattern of the mitochondrial supercomplexes as obtained after BN-PAGE and in-gel staining for CcO activity (Fig. 3D, lanes 1-4) . Four main bands exhibited in-gel CcO activity that were attributed to monomeric complex IV, dimeric complex IV (IV 2 ), and to two supercomplexes formed by the association of CcO and bc 1 complex (III 2 IV 1 and III 2 IV 2 ) (Fig. 3D, lanes 1 and 2) . The in-gel CcO activity after digitonin solubilization was considerably higher than the one observed after LM solubilization (Fig. 3A, lanes 10 and 12) , but was completely sensitive to cyanide (Fig. 3D, lanes 3 and 4) . Nevertheless, in gel-staining of CcO activity of the Δcox2+Cox2 W56R transformant was only 65% of the one observed in the WT strain, as judged by densitometric analysis. Decrease of the in-gel CcO activity in the Δcox2+Cox2 W56R transformant was especially notable in the III 2 IV 1 and III 2 IV 2 supercomplexes, indicating a lower accumulation of supercomplexes when the amounts of CcO are limiting. In order to ascertain the presence of less supercomplexes in the Δcox2+Cox2 W56R transformant, equivalent lanes of digitonin-solubilized mitochondria were subjected to BN-PAGE followed by denaturing 2D-SDS-PAGE and Western blotting using antiCox3 and anti-FeS antibodies. Less Cox3 antibody staining was found associated to the III 2 IV 1 and III 2 IV 2 supercomplexes in the Δcox2+ Cox2 W56R transformant as compared to the WT strain. In addition, while all the bc 1 complex of the WT strain was found associated to CcO in the III 2 IV 1 and III 2 IV 2 supercomplexes, the presence of free, monomeric bc1 complex (III 2 ) could be detected only in the Δcox2+Cox2 W56R strain ( Fig. 3E) . All together, these data strongly suggest that less supercomplexes containing CcO are accumulated in the Δcox2+ Cox2 W56R transformant. ) mitochondria. The isolated complexes catalyzed electron transfer from yeast cytochrome c to oxygen in a fully cyanide-sensitive reaction. The specific activities of oxygen uptake measured in the presence of 100 μM reduced yeast cytochrome c were 6.4 and 4.8 ngat O/nmol aa 3 /min for the CcO WT and the CcO W56R respectively. Higher rates of oxygen uptake were observed in the presence of 100 μM reduced horse heart cytochrome c, 9.2 and 7.4 ngat O/nmol aa 3 /min for the CcO WT and the CcO W56R respectively. This data indicate that the CcO W56R exhibits 75 to 80% of the activity of the CcO WT enzyme. Fig. 4A (lanes 1 and 2) shows the polypeptide pattern after SDS-tricine-PAGE of the isolated enzymes. Both CcO exhibited similar polypeptide compositions. To confirm the identity of the three main polypeptides, Cox1, Cox2 and Cox3, Western blot analysis using specific antibodies against these subunits was carried out (Fig. 4B, lanes 3-8) . The antibodies recognized all three subunits both in the CcO WT (Fig. 4B, proteolitically processed once by removal of its 15-residues leader sequence, while the allotopically-expressed Cox2 W56R precursor must be proteolitically processed twice, first by the removal of the MTS from Oxa1, then by the removal of the 15-residue leader sequence. Most probably, removal of the MTS occurs in the mitochondrial matrix, while the processing of the leader sequence should take place in the mitochondrial inter-membrane space [11, 55] . These data led us to conclude that Cox2 W56R is structurally identical to Cox2
Isolation and partial characterization of CcO from WT and the
WT . Since the W56R mutation seems to only slightly impair CcO activity, it can also be concluded that the lower respiratory activity of the Δcox2+Cox2 W56R transformant is mainly due to the presence of lower steady-state levels of assembled complex IV. Therefore, the import, maturation, or assembly of the allotopically-expressed Cox2 W56R must be the limiting step of complex IV biogenesis in the Δcox2+Cox2 W56R transformant.
Regulation of Cox1 biogenesis by the presence of an allotopicallyexpressed Cox2
W56R
In vivo or in-organello pulse labeling of Cox1 with [
35 S] methionine is strongly reduced in the presence of mutations that block CcO assembly. This reduced labeling of Cox1 is due to a decrease in Cox1 synthesis [6] . Thus, absence of mitochondrial Cox2 synthesis is one of the multiple factors that down-regulates Cox1 biogenesis. We asked whether the allotopically-expressed Cox2 W56R would restore mitochondrial Cox1 synthesis; thus indicating a normal CcO assembly. In vivo pulse labeling of yeast with [
35 S] methionine in the presence of cycloheximide was performed, followed by SDS-glycine-PAGE and analysis of the radioactive label. The synthesis of Cox1 was severely diminished in the Δcox2 mutant as compared to the WT strain (Fig. 6, lanes 1 and 6) . As expected, no band that would indicate Cox2
WT synthesis was observed in the Δcox2 mutant ( lane 6). The polypeptide pattern of mitochondria-synthesized proteins in the Δcox2 + Cox2 W56R transformant also exhibited the absence of a mitochondrion-synthesized Cox2 WT band as expected (Fig. 6, lane 11) . Nevertheless, Cox1 synthesis in the Δcox2 + Cox2 W56R transformant was equivalent to the one observed in the WT strain (Fig. 6, lanes 1 and 11) . Thus, the presence of the allotopically-expressed Cox2 W56R protein in mitochondria, allows Cox1 biosynthesis to be restored to levels equivalent to those found in the WT strain. Furthermore, a pulse-chase experiment showed that both the Cox1 subunit synthesized by the WT and by the Δcox2 + Cox2 W56R transformant were stable for as long as 4 h (Fig. 6 , lanes 2-5 and 12-15 respectively), suggesting that Cox1 is being incorporated correctly into CcO in both strains.
Discussion
In yeast, as in the vast majority of eukaryotes, Cox2 is encoded in the mitochondrial genome. However, in some species the mitochondrial gene COX2 has naturally migrated to the nucleus, either as an intact gene (as in legumes) [56] or as split genes (as in green algae and apicomplexan parasites) [57] [58] [59] . Efforts have been made to emulate the natural migration of mitochondrial genes to the nucleus by engineering the corresponding mitochondrial COX2 gene to allow its expression from the nucleus, the so called allotopic expression. Daley et al. [60] were able to internalize in vitro synthesized soybean Cox2 carrying two point mutations into isolated soybean mitochondria. More recently Supekova et al. [1] expressed a Cox2 W56R precursor in vivo,
successfully restoring respiration in a Δcox2 yeast mutant. Several modifications must be made on the original mitochondrial genes to allow its allotopic expression. The mitochondrial gene sequence must be recoded in accordance with the nuclear genetic code and with its codon usage bias, and a nucleotide sequence encoding an appropriate MTS must be added, in order to ensure correct delivery of the cytosol-synthesized protein to mitochondria. Diminished hydrophobicity seems also to be a key feature to allow import of mitochondrial membrane proteins whose genes naturally migrated to the nucleus or that they were engineered to be synthesized in the cytosol [60] [61] [62] [63] [64] [65] [66] . For example, the nucleus-encoded subunits Cox2A, Cox2B, Cox3, Atp6, Nad3 and Nad4L of chlorophycean algae exhibit reduced hydrophobicity compared to their mtDNA-encoded counterparts [29, 57, 58, 67] . For algal Cox3 and Atp6, the decrease of mean hydrophobicity occurs mostly in those TMS that are not crucial for function or that are not involved in subunit-subunit interactions [29, 58, 68] . A similar observation was made with the mitochondrial sdh3 gene, encoding a succinate dehydrogenase (complex II) subunit, relocated to the nucleus in angiosperms; its protein product also exhibits a diminished hydrophobicity when compared to its mitochondrial counterparts [69] . Also, in leguminous species that express both mitochondrial and nuclear COX2 genes, the nucleus-encoded Cox2 proteins exhibit a lower hydrophobicity than their mitochondrion-encoded counterparts. It was clearly demonstrated that two amino acid changes in the first TMS of soybean Cox2 that introduced less hydrophobic residues, were necessary to allow the in vitro import of the protein by isolated mitochondria [60] . Also, the W56R mutation, that diminishes the hydrophobicity of the first TMS of yeast Cox2, was required to achieve functional import of this subunit into mitochondria in vivo [1] . The W56R mutation was originally numbered according to the Cox2 precursor that contained the 15-residue leader sequence, so it actually corresponds to W41R in the sequence of the mature Cox2.The mutation is located in a region of the TMS close to the face of the inner mitochondrial membrane exposed to the mitochondrial matrix and in close proximity to Cox7a (Fig. 7) . All cytosol-expressed Cox2 subunits that are imported into mitochondria exhibit, in average, diminished hydrophobicity of the first TMS and a slightly increased hydrophobicity in the second TMS [70] . The lower average hydrophobicity of the first TMS would allow its full translocation to the mitochondrial matrix through the Tim23 translocon, while the second TMS would be retained by Tim23 and laterally inserted into the inner mitochondrial membrane [55] . These changes in the average hydrophobicity of the two TMS of a cytosol-synthesized Cox2 ensures the proper insertion of this subunit in the inner mitochondrial membrane in order to reach its characteristic topology, with both the N-and C-termini exposed towards the IMS.
Mutations that diminish hydrophobicity in a TMS may allow import of the corresponding protein into mitochondria, but at the same time, they may affect the assembly of the subunit, or its stability, or even abolish the function of the whole complex. In the case of the allotopically-expressed Cox2 W56R , the oxygen uptake of CcO W56R in the presence of cytochrome c is not severely impaired, since only 20-25% of the oxygen-uptake activity was lost. The CcO W56R contains an arginine with a positive charge that substitutes a tryptophan that is exposed towards Leucine 24 in Cox7a, according to a model built with the yeast CcO subunits based on the bovine CcO crystallographic structure (Fig. 7) . Since a charged residue is not expected to interact in an hydrophobic milieu, the presence of R 56 may induce some conformational changes that may diminish the activity of the enzyme. , these are enough to sustain growth rates of the Δcox2 + Cox2 W56R transformant in liquid media containing non-fermentable carbon sources, albeit at slightly lower rates than those of the WT strain. CcO assembly is a linear process, the first assembly intermediate is the Cox1 subunit, and the rest of the subunits and cofactors are thought to be added in a sequential order [52, 71] . In mutants where CcO assembly is blocked, most of the subunits are rapidly degraded, but also the synthesis of Cox1 is down-regulated, and this process depends on the Cox1 carboxyl-terminal end [72] [73] [74] . The regulation of the Cox1 synthesis prevents the formation of a pro-oxidant intermediates containing unassembled heme a 3 [75] . As expected, Cox1 synthesis was decreased in the Δcox2 mutant as compared to the WT strain. Nevertheless, in the presence of the allotopically-expressed Cox2 W56R , mitochondrial Cox1 synthesis was restored to normal levels. This indicates that the presence of Cox2 in the inner mitochondrial membrane, independently of its origin (mitochondrion-or cytosol-synthesized), allows for a normal Cox1 synthesis in the organelle. In addition, pulse-chase experiments suggest that the newly synthesized Cox1 subunit in the complemented strain is stable for several hours, indicating that Cox1 is being incorporated correctly into the inner mitochondrial membrane when adequate steady-state levels of the allotopically-expressed Cox2 W56R are present. This observation strongly supports that the W56R mutation present in Cox2 does not impair the CcO biogenesis, however we cannot rule out a possible interference of the W56R mutation in the assembly of Cox2 to the enzyme. Two supercomplexes involving CcO (III 2 IV 2 and III 2 IV 1 ) have been previously identified and characterized in yeast [76] [77] [78] [79] [80] . Two additional protein components, Rcf1 and Rcf2, that seem to be critical in maintaining the interaction between CcO and the bc 1 complex in these supercomplexes, were recently described [81] [82] [83] . Here, carrying BN-PAGE in the presence of digitonin, we obtained data that suggest that less supercomplexes containing CcO are accumulated in the Δcox2+Cox2 W56R transformant as compared to the WT strain. Since CcO seems to be accumulating 40% less efficiently in the Δcox2+ Cox2 W56R transformant, this mutant may also tend to assemble less supercomplexes. Alternatively, the W56R mutation may somehow destabilize the CcO-bc 1 interactions in the supercomplexes and favor its dissociation in the presence of digitonin. . This observation discards the possibility of a highly improbable reversion that would restore the integrity of the interrupted mitochondrial COX2 gene and therefore reactivate Cox2
WT synthesis inside mitochondria. Among others, this kind of experiments, are indispensable to assess a successful allotopic expression [84] . False positives may arise due to reversions of the original mutations in the mitochondrial genes, especially when single-point mutations are involved, as in the case of several mitochondrial mutations described in human patients (http://www.mitomap.org/MITOMAP). As mentioned above, allotopic expression is an experimental strategy upon which gene therapies against human mitochondrial diseases may be developed, and it may be based on either the import of cytosol-synthesized proteins [65, 85] or as recently demonstrated, on the import of its corresponding RNAs [86] . However, the field of allotopic expression of human mitochondrial genes is debatable [18] . While several groups have provided promising evidence for the allotopic expression of several integral membrane proteins [87] [88] [89] [90] [91] [92] , others have failed to observe functional integration of cytosol-synthesized membrane-embedded proteins [64, 66, 84, 93] . Here, using yeast as a model system, we have provided unambiguous biochemical evidence for the functional assembly of a cytosolsynthesized Cox2 subunit into CcO, and provided information on the maturation process that the corresponding precursor underwent during its import into mitochondria. To our knowledge, this is the first biochemical characterization of a mitochondrial OXPHOS complex carrying an allotopically-expressed subunit with two TMS.
